Author:
Lu Da-Yong,Che Jin-Yu,Yarla Nagendra Sastry,Wu Hong-Ying,Lu Ting-Ren,Xu Bin,Wu Shu-Yun,Ding Jian,Lu Yi,Zhu Hong
Abstract
The causality and etio-pathologic risks for patients with Type 2 Diabetes (T2DM) are important areas in modern medicine. Disease complications are largely unpredictable in patients with T2DM. In the future, we welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments and management with higher efficiency and less cost. Expanding medical knowledge, behavior/life-style notification in healthcare, modern genetic/bioinformatics diagnostic promotion, clinical developments (Traditional Chinese Medicine and personalized medicine) and new drug developments - including candidate drug targets should be implemented in the future. These efforts might be useful avenues for updating anti-diabetic therapeutics globally. This article aims at introducing this information for T2DM treatment boosts.
Publisher
Bentham Science Publishers Ltd.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference59 articles.
1. Yang W, Lu J, Weng J, et al.
Prevalence of diabetes among men and women in China.
N Engl J Med
2010;
362
(12)
: 1090-101.
2. Lu DY, Che JY, Yarla NS, et al.
Diabetes prevention and treatments, a specific topic for modern medicines.
J Metab Syndr
2017;
8
(3)
: 231.
3. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE.
Diabetes: A 21st century challenge.
Lancet Diabetes Endocrinol
2014;
2
(1)
: 56-64.
4. Fuchs S, Henschke C, Blümel M, Busse R.
Disease management programs for type 2 diabetes in Germany: A systematic literature review evaluating effectiveness.
Dtsch Arztebl Int
2014;
111
(26)
: 453-63.
5. Thepwongsa I, Kirby C, Schattner P, Shaw J, Piterman L.
Type 2 diabetes continuing medical education for general practitioners: What works? A systematic review.
Diabet Med
2014;
31
(12)
: 1488-97.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献